ResMed stock slips 1.31% and underperforms market

7 articles · Updated · MarketWatch · May 7

Shares closed at $206.89 on Thursday as the S&P 500 fell 0.38% to 7,337.11 and the Dow Jones Industrial Average dropped 0.63% to 49,596.97.
The medical device maker finished 29.58% below its 52-week high of $293.81, reached on 22 August.
Trading volume rose to 1.3 million shares, above the company's 50-day average of 1.1 million, during a broadly weak session for equities.

ResMed's profits are soaring, so why is Wall Street betting on its decline?

Will popular weight-loss drugs make ResMed’s billion-dollar sleep business obsolete?

Can a new acquisition pivot ResMed's strategy against the GLP-1 drug threat?